Tokyo Tape
Sign in

ADR Biomedical Holdings

3750.TInformation & Communication
Filed as FRACTALE Corporation (2022-06–2022-06), Cytori Cell Research Institute,Inc. (2022-08–2025-11), ADR120S, Inc. (2025-11–2026-06)
Key numbers · FY ended 2026-03
Revenue¥51m-58.3% YoYOperating income−¥906m—Net income (owners)−¥397m—Total assets¥368m-89.6% YoYEPS (basic)¥-44.46+81.5% YoY

Full financial history and reports →

Stock price3750 · View chart ↗

Open the price chart on TradingView.

Latest filings
Mon, Jun 29 · JST1 filing
10:33MATERIALADR Biomedical Holdings · Change of representative director
Fri, May 8 · JST1 filing
16:205% STAKEADR Biomedical Holdings · TOKYO WELD CO., LTD. + 2 joint holders · 9.22% → 14.58%+5.36pp
Wed, Oct 29 · JST1 filing
15:40MATERIALADR Biomedical Holdings · Change in parent company or specified subsidiary
Wed, Oct 22 · JST2 filings
16:30MATERIALADR Biomedical Holdings · Change in major shareholder11:465% STAKEADR Biomedical Holdings · FTL Capital Management K.K · 11.05%new 11.05%

All filings →

Major holders (5%+) · 6
HolderStakeChangeFiled
Hashimoto Masamichi18.50%—2025-03-06
HG CAPITAL CO., LTD.13.14%-2.83pp2024-03-27
FTL Capital Management K.K11.05%—2025-10-22
Catalyst Investment Group Co., Ltd.10.67%+1.79pp2024-07-26
TOKYO WELD CO., LTD.9.22%—2026-05-08

Each holder's own ratio from its most recent large-shareholding report. All 6 holders and full history →